VX11-770-109 Roll-Over Study Paediatric CF CFTR gating mutation
Research type
Research Study
Full title
A Phase 3, 2-Arm, Roll-Over Study to Evaluate the Long-term Safety and Pharmacodynamics of Ivacaftor Treatment in Pediatric Subjects With Cystic Fibrosis and a CFTR Gating Mutation
IRAS ID
131110
Contact name
Jane Davies
Contact email
Sponsor organisation
Vertex Pharmaceuticals Incorporated
Eudract number
2012-000386-20
ISRCTN Number
n/a
Clinicaltrials.gov Identifier
n/a
REC name
East Midlands - Nottingham 2 Research Ethics Committee
REC reference
13/EM/0268
Date of REC Opinion
31 Jul 2013
REC opinion
Favourable Opinion